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A B S T R A C T
Objective: In epidemiological and clinical studies, whole blood assay (WBA) has been used as a measure to
characterize inter-individual diﬀerences in the cytokine response of individuals exposed to inﬂammatory agents,
such as endotoxins. Several short-time repeatability studies have shown stable cytokine levels in individuals over
periods of days, weeks or months, but little is known about the long-term stability of cytokine reactivity.
Methods: We studied cytokine response levels in LPS-stimulated whole blood in a cohort of 193 farmers and
agricultural industry workers at two time points with a ﬁve-year interval.
Results: IL-10 and IL-1β responses measured with a ﬁve-year time interval showed a weak positive correlation
(r=0.22 and 0.27, respectively), whereas no correlation was observed for TNFα (r=0.06). Cytokine reactivity
measured repeatedly at the same time point showed high correlations (IL-10 r=0.80, IL-1β r=0.53 and TNFα
r=0.74), suggesting that the observed weak correlations over time are reﬂective of actual variations in cytokine
reactivity over time.
Conclusions: Repeatability of ex vivo cytokine reactivity showed to be diﬀerential for the measured cytokines,
being more stable for IL-10 and IL-1β than for TNFα. However, in general, repeatability of ex vivo cytokine
reactivity was weak, reﬂecting that cytokine reactivity can mostly be explained by (short term) intra-individual
(immunological) or time varying environmental factors and less by genetic or other time-invariant factors.
Therefore, WBA should be regarded as a viable tool to study relationships with current health status and ex-
posure, and only partially as a predictor for a future response.
1. Introduction
The whole-blood stimulation assay (WBA) is a widely used method
to study patterns of individual cytokine reactivity in clinical (Segre and
Fullerton, 2016) and epidemiological studies (Smit et al., 2009). In vitro
cytokine response following lipopolysaccharide (LPS) stimulation has
been shown to predict clinical outcomes (Segre and Fullerton, 2016),
and characterize diﬀerences in individual susceptibility (Smit et al.,
2009). For instance, an ex vivo inﬂammatory response to LPS in a WBA
reﬂects to a large extent whether individuals are susceptible to adverse
respiratory eﬀects induced by high occupational endotoxin exposure
(Smit et al., 2009). It has been shown that induced cytokine production
is highly reproducible over short periods of time such as weeks or
months (Wouters et al., 2002; Damsgaard et al., 2009) and that it has a
genetic component (de Craen et al., 2005). However, it is not clear
whether the observed induced cytokine production is consistent over
time and represents a stable personal trait or whether cytokine re-
sponses merely depend on recent immunological challenges including
disease exacerbations, (respiratory) infection episodes and develop-
ment of allergies.
To investigate the long-term stability of induced cytokine reactivity,
we performed a WBA using blood samples collected from the same 193
individuals over an interval of ﬁve years. We measured IL-10, IL-1β and
TNFα in supernatants of LPS-stimulated whole blood at baseline and
after ﬁve years of follow-up. Our cohort was set up to study the eﬀect of
occupational endotoxin exposure on respiratory health and allergy
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(Smit et al., 2009). Cytokine reactivity at baseline was associated with
an increased prevalence of endotoxin-related respiratory symptoms. To
further evaluate the predictive value of cytokine responsiveness, we
need more information on the stability of being a low or high responder
in a WBA over an extended period of time.
2. Methods
2.1. Study population
We conducted a ﬁve-year follow-up study in endotoxin-exposed
farmers and agricultural workers. From the 341 participants at baseline,
193 participated at follow-up. At both time points we collected serum to
determine IgE levels and participants ﬁlled in a questionnaire on gen-
eral characteristics, respiratory health, allergies and whether they had
experienced a chronic or acute infection, common cold or inﬂuenza in
the previous week (infection), as described previously (Spierenburg
et al., 2017). Atopy was deﬁned as positive speciﬁc serum IgE for any of
the tested allergens: Grass mix, house dust mite (HDM), cat and dog.
Full-shift inhalable dust samples were collected in a subset of partici-
pants and analyzed for endotoxin levels by LAL assay. Exposure was
then modeled for each participant based on job description
(Spierenburg et al., 2017).
The study protocol was approved by the University Medical Centre
Utrecht ethics committee and all participants gave written informed
consent both at baseline and follow-up.
2.2. Whole blood assay
Both at baseline and at follow-up a WBA with LPS as stimulant was
conducted. For the WBA, blood was collected in the morning at the
workplace in pyrogen free heparin tubes (BD, Vacutainer) and stored on
ice until use. Time between drawing blood and WBA testing was re-
corded. After transport to the lab, WBA was initiated by transferring
80 μl whole blood to sterile, pyrogen-free U-bottom 96-wells plates
(Greiner) and diluted with an equal volume of RPMI with 100 U/ml
penicillin and 100mg/ml streptomycin (Invitrogen Life Technologies
Inc.). LPS (Sigma Aldrich) was added to a ﬁnal concentration of 1 ng/ml
as stimulant. For each participant a sham exposed control was included
which contained only RPMI with penicillin and streptomycin. All sti-
mulations were performed in triplicate on the same plate. Plates were
incubated for 18 h in a CO2 incubator(37 °C, 5% CO2,> 95% relative
humidity) after which they were centrifuged (15min at 1000 g) and
supernatants were transferred to 0.5 ml push cap tubes (Micronic Inc.)
and stored at −20 °C until cytokine quantiﬁcation.
2.3. Cytokine quantiﬁcation
We determined IL-1β and TNFα as these cytokines are known to be
involved in endotoxin-induced inﬂammatory responses. IL-10 was in-
cluded as a marker of innate cytokine reactivity (Smit et al., 2009).
To determine induced cytokine production, levels of IL-10, IL-1β
and TNFα were measured in the supernatants using multiplex tech-
nology. For the samples at baseline, we used the in-house Bio-Plex assay
from De Jager, et al.(De Jager et al., 2003), and at follow-up the Bio-
Plex Pro Assay from Bio-Rad according to manufacturer's protocol. The
lower limits of detection (LOD) were 2.3 pg/ml and 0.54 pg/ml for IL-
10, 20.8 pg/ml and 6.19 pg/ml for IL-1β and 2.2 pg/ml and 5.86 pg/ml
for TNFα for the in-house and Bio-Plex Pro assay respectively. LPS-in-
duced cytokine production was calculated by subtracting cytokine
concentrations of unstimulated samples from those of stimulated sam-
ples. Unstimulated cytokine concentrations were mostly below LOD
both at baseline and follow-up. In a minority of subjects (n=0 at
baseline and n=5 for TNFα and n=1 for IL-10 at follow-up) un-
stimulated cytokine concentrations were higher than stimulated con-
centrations. In that case, a value of 2/3 of LOD was assigned.
For a subset of 17 samples collected at follow-up we determined the
cytokine production in duplicate stimulated wells to determine the re-
peatability of the WBA stimulation. To test the comparability of the
assays, we re-tested a subset of 30 stored samples from baseline with
the Bio-Plex Pro Assay from Bio-Rad.
2.4. Data analysis
Samples< LOD were replaced by⅔ of the lowest detected value per
plate, samples> LOD were replaced with 1.5 times the highest detected
value per plate. Cytokine levels were ln-transformed for analysis as they
were right-skewed.
Time between blood collection and start of WBA averaged
4.1 ± 1.4 h at baseline and 4.5 ± 1.3 h at follow-up. We previously
showed an inverse relation between time-to-incubation and cytokine
productivity (Smit et al., 2009). At baseline IL-10, IL-1β and TNFα
production decreased by 8, 12, and 32% per hour, respectively. At
follow-up the decrease was 8, 14 and 29% per hour respectively, based
on linear regression analysis for the eﬀect of time-to-incubation with ln-
transformed cytokine production adjusted for endotoxin exposure.
Cytokine concentrations were adjusted for time-to-incubation prior to
further analysis, as was done at baseline (Smit et al., 2009).
We investigated the correlation between baseline and follow-up
WBA cytokine production by calculating the Pearson product-moment
correlation coeﬃcient. To evaluate whether the variation was due to
actual intra-personal variation over time and not due to assay noise, we
also calculated correlations for the WBA duplicates at follow-up and re-
measured baseline samples.
Additionally we analyzed categorized induced cytokine levels based
on tertiles (low, intermediate or high responder) by calculating the
kappa (κ, squared weights).
Data was analyzed using SAS 9.4 and R 3.2.2.
3. Results
3.1. General characteristics
General characteristics of the study population at baseline and
follow-up remained mostly similar over time (Table 1). However, pre-
valence of smoking decreased slightly, as did the prevalence of self-
reported asthma, while the prevalence of wheeze increased con-
siderably between baseline and follow-up. A more in-depth analysis of
the diﬀerences in allergy-related variables between baseline and follow-
up has been published elsewhere (Spierenburg et al., 2017). We did not
ﬁnd an association between a change in any of the general
Table 1
Characteristics of the study population at baseline and follow-up.
Baseline Follow-up
Subjects (n) 193 193
Age⁎ (years; mean (SD)) 42.1 (9.2) 46.9 (9.2)
Gender⁎ (female; n (%)) 19 (9.8) 19 (9.8)
Farm childhood (n (%))⁎ 109 (56.5) 105 (54.7)
Smoking (n (%))⁎ 49 (25.4) 43 (22.4)
Endotoxin exposure (EU/m3; GM (GSD)) 298 (4.6) 266 (5.0)
Asthma (n (%))⁎ 18 (9.3) 10 (5.2)
Wheeze (n (%))⁎ 24 (12.4) 36 (18.8)
Infection (n (%))⁎ 61 (31.6) 58 (30.1)
Allergy (n (%))⁎ 57 (29.5) 58 (30.2)
Hay fever (n (%))⁎ 27 (14.0) 28 (14.6)
Total IgE(IU/ml; GM (GSD)) 24.8 (7.2) 23.2 (6.3)
Atopy (n (%)) 63 (32.6) 65 (33.7)
Grass IgEpositive (n (%)) 40 (20.7) 41 (21.2)
HDM IgEpositive (n (%)) 44 (22.8) 41 (21.2)
Cat IgEpositive (n (%)) 4 (2.1) 6 (3.1)
Dog IgEpositive (n (%)) 2 (1.0) 3 (1.6)
⁎ Self-reported
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characteristics and change in z-score of cytokine expression (data not
shown).
3.2. Levels of cytokine response at baseline and follow-up
To compare absolute cytokine response levels between baseline and
follow-up and between the two analysis methods, we determined in-
duced cytokine response levels at both time points. A signiﬁcant dif-
ference was observed between induced cytokine production at the two
time points (p < .0001 for all cytokines; Fig. 1). In unstimulated
samples, cytokines were usually below limit of detection at both time
points. In those cases where cytokine concentrations were measurable
in unstimulated samples, a similar absolute level diﬀerence between the
two time points is observed. It is likely that the absolute diﬀerence in
cytokine levels at baseline and follow-up is partly due to a diﬀerence in
assays used, as the cytokine concentrations of baseline samples re-
measured at follow-up with the Bio-Plex Pro assay were in the same
range as the cytokine levels of the follow-up samples measured with the
same assay. Moreover, moderate to good correlation was found be-
tween cytokine levels determined at baseline and re-measured at
follow-up, see Fig. 2. This indicates that although we used two diﬀerent
assays, the inﬂuence on the correlation between the two time points is
limited.
3.3. Correlation between cytokine response at baseline and follow-up
To estimate the stability of cytokine reactivity over time we tested
correlations between the cytokine levels in the WBA of the 193 parti-
cipants included both at baseline and follow up. We observed weak but
positive correlations between cytokine levels at baseline and follow-up
for IL-1β (r=0.27, 95%CI: 0.13–0.39) and IL-10 (r=0.22,
95%CI:0.08–0.35), whereas there was no correlation for TNFα
(r=0.06, 95%CI: -0.08-0.20; Fig. 3). Evaluation of categorized induced
cytokine levels based on tertiles showed similar results for all three
cytokines: IL-1β κ=0.206, IL-10 κ=0.134 and TNFα κ=0.052 (see
Table 2 for contingency table). The majority of participants either re-
mained in the same response class (39%, 40% and 46% of participants
for IL-10, IL-1β and TNFα respectively) or changed to the adjacent class
from baseline to follow-up (44%, 44% and 46% for IL-10, IL 1β and
TNFα respectively). A change from lowest to highest tertile or vice versa
was less common and occurred in 17%, 16% and 18% of participants
for IL-10, IL 1β and TNFα respectively.
To get an insight into the assay reproducibility, we looked into the
correlation between duplicate samples. These correlations were mod-
erate to high: IL10 r=0.80, p < .0001; IL-1β r=0.53, p < .03; TNFα
r=0.74, p < .001, indicating that the observed correlations between
t=0 and t=5y will for a large part be due to actual diﬀerences over
time.
Fig. 1. Induced cytokine concentrations at baseline and follow-up. Absolute cytokine levels are shown as 5-95th percentile box and whisker plots.
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4. Discussion
In this study, we determined the stability of cytokine expression
over time by correlating measured induced cytokine responses in 193
individuals at two time points with a ﬁve year interval. In general,
stability over time was limited, yet LPS responsiveness for IL-10 and IL-
1β showed to be somewhat more stable over time than TNFα. Research
by May, et al.(May et al., 2009) observed a similar result in a study with
follow-up time of 1 year for IL-10 and TNFα (IL-10: r=0.48, p < .001;
TNFα: r=0.15, p= .087), suggesting that TNFα may be more variable
in general, while induced IL-10 production is more stable. This implies
that IL-10 reactivity better reﬂects an innate inﬂammatory tendency
while TNFα may predominantly reﬂect inﬂuence of recent im-
munological challenges.
There are several factors which may impact short term cytokine
reactivity and thus may account for the low degree of correlation be-
tween two measurements with a ﬁve-year interval. First, there are
methodological factors. In previous studies, several methodological
factors have been reported to inﬂuence observed cytokine reactivity
such as the number of cells in the assay (Hartmann et al., 2016), time-
to-incubation (Bakiyeva et al., 2005), storage conditions of blood
samples before usage in WBA and even the type of plastic ware used
(Hartmann et al., 2016). We were aware of these prior to this study,
therefore, to minimize the eﬀect of methodological diﬀerences, we used
the same protocol and type of plastic ware at both time points. How-
ever, as a ﬁxed volume of blood was used per stimulation, the number
of cells for each WBA was not controlled for as the cell number was not
available at follow-up. A possible intra-individual diﬀerence in cell
count may have introduced some variation. However, we performed a
cell count for the samples at baseline and adjustment for the cell
number in the baseline analyses only slightly attenuated the
associations between endotoxin exposure and IL-1β and IL-10 (Smit
et al., 2009).
Another methodological factor to be considered is the inﬂuence of
varying time-to-incubation. Several studies have shown that cytokine
responsiveness is inversely related to time-to-incubation (Smit et al.,
2009; Van Der Linden et al., 1998; Egger et al., 1997). We took this into
account by applying modeled correction factors to the cytokine re-
sponse prior to the analyses. Basis of this correction factor is the as-
sumption that time to incubation is log-linearly associated with
cytokine levels, while in fact the actual decline in cytokine respon-
siveness might follow a diﬀerent course such as an exponential curve.
However, a sensitivity analysis calculating the correlations with the
unadjusted cytokine responses did only marginally change the results,
which indicates that even though there is an eﬀect of time-to-incuba-
tion on whole blood cytokine reactivity, the overall correlation between
cytokine responses is a robust one.
Non-methodological factors which may impact repeated cytokine
reactivity are time varying environmental and intra-individual (im-
munological) factors. Endotoxin exposure has previously been shown to
inﬂuence cytokine reactivity (Castellan et al., 1984; Smit et al., 2011),
but also glucans (Wouters et al., 2002) and other exposures may induce
a cytokine response in vivo, both in the short and long term. As en-
dotoxin exposure has been shown to inﬂuence ex vivo cytokine re-
activity, it might be of inﬂuence on the correlations found between the
time points in this study. However, there was no association between
change in endotoxin exposure and change in cytokine reactivity. Im-
munological factors that might inﬂuence cytokine reactivity are (re-
cent) infections and immune modulating medication. We did not have
information on medication use, yet we did have self-reported in-
formation on infections in the week prior to WBA. Reported chronic or
acute infection, common cold or inﬂuenza in the week prior to WBA
Fig. 2. Cytokine levels of 30 samples from baseline, analyzed at baseline and re-analyzed with the new assay at of follow-up. Scatterplot with correlation coeﬃcient
(r) and p-value. Cytokine levels presented in pg/ml.
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was however not associated with cytokine responses, and thus is not a
likely explanation for the observed weak correlations over time. Ad-
ditionally a change in atopy status was not associated with a change in
cytokine reactivity. Another intra-individual factor which might inﬂu-
ence cytokine reactivity is smoking. However, at baseline we did not
ﬁnd an association between smoking habit and any of the cytokines
(Smit et al., 2009). Also in the current study we did not ﬁnd a corre-
lation between change in smoking habit and change in cytokine re-
sponsiveness.
A shortcoming of our study is the substantial drop out of partici-
pants between baseline and follow-up: 43% of the participants were lost
to follow-up (included in follow-up (FU) n=193; lost to follow-up
(LTF) n=148). This may have led to selection bias, although this is of
little importance for the present research question on intra-individual
repeatability of cytokine responsiveness. We previously reported that
there is no evidence of healthy worker selection based on atopic sen-
sitization, lung function and respiratory symptoms (Spierenburg et al.,
2015). In this study, we did not observe any evidence of a healthy
worker selection based on induced cytokine production. Baseline
cytokine levels were similar for those LTF and those included in FU (IL-
10: LTF 439 ± 2.5 pg/ml, FU 479 ± 2.3 pg/ml, p= .35; IL-1β: LTF
420 ± 2.2 pg/ml, FU 419 ± 2.3 pg/ml, p= .97 and TNFα: LTF
148 ± 4.1 pg/ml, FU 167 ± 3.1 pg/ml, p= .36).
Organic dust exposure has been linked to adverse respiratory eﬀects
and a protective eﬀect on allergy (Smit et al., 2008), and endotoxin
sensitivity is known to vary from person to person (Kline et al., 1999).
With the immune system being an important link between organic dust
exposure and its possible health eﬀects, it is a logical factor to con-
tribute to these interpersonal diﬀerences. Most studies focusing on
immunological inter-personal diﬀerences as assessed by WBA present it
as a personal characteristic and thereby implicitly assume this is a more
or less stable trait over longer periods of time. The genetic make-up
could underlie this personal characteristic and several studies in-
vestigated a possible link between cytokine responses and candidate
genes, showing that there is indeed a relationship between certain ge-
netic markers and induced cytokine production (Westendorp et al.,
1997) and between genetic markers and endotoxin related health out-
comes (Smit et al., 2011). We did indeed ﬁnd weak positive correlations
between cytokine levels over a period of 5 years for IL-1β and IL-10.
This implies that cytokine reactivity has at least some stability over
Fig. 3. Scatterplot with correlation coeﬃcient (r) and p-value for cytokine levels of 193 participants at baseline and follow-up. Cytokine levels presented in pg/ml.
Table 2
Contingency table showing number of participants categorized by induced cytokine reactivity at baseline and follow-up, based on tertiles per time-point.
Follow-up
IL-10 IL-1β TNFα
Low Med High Low Med High Low Med High
Baseline Low 26 19 19 26 25 14 25 23 16
Med 24 22 18 23 21 20 21 20 24
High 14 24 27 16 17 31 19 21 24
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time, which suggest a partial role of genetic factors. The marginal sta-
bility of cytokine levels found in the current study are in line with a
study of 210 twins where the normalized heritable inﬂuence in serum
proteins was estimated to be<0.25 for IL-10 and < 0.40 for IL-1β and
TNFα (Brodin et al., 2015). Although the repeatability over time is
underestimated because of methodological variation, we found rea-
sonably good assay reproducibility that could not fully explain the
limited correlation over ﬁve years. Therefore, we conclude that there is
substantial intra-individual variation in responsiveness over time,
which is likely due to triggers with more acute eﬀects. Although in our
study we did not ﬁnd a relation between recent, self-reported infections
in the previous week and cytokine reactivity, there may be other factors
such as environmental factors or more severe immunological challenges
that impact cytokine reactivity in the short term. A study by Castellan,
et al. (Castellan et al., 1984) already showed an attenuation of the
cytokine reactivity in response to repeated endotoxin exposure,
showing that although there is a relation between environmental fac-
tors and cytokine reactivity, this is less a stable state, and more an
adaptive feedback-loop.
In conclusion, cytokine responsiveness of IL-1β and IL-10 are to
some extent stable over a 5-year time period, while TNFα is more
variable. This suggest that investigating cytokine responsiveness in re-
lation with health outcomes is only partly predictive for future re-
sponses, yet may provide insight in immune regulation underlying
current observed responses.
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